Transactions
12
Insider / HCA Healthcare, Inc.
McAlevey Michael R
EVP & Chief Legal & Admin Off. at HCA Healthcare, Inc.
- Company
- HCA Healthcare, Inc.
- Ticker
- HCA
- First filing on record
- November 5, 2025
- Latest trade on record
- August 26, 2026
- SEC filings
- EDGAR ↗
McAlevey Michael R, EVP & Chief Legal & Admin Off. at HCA Healthcare, Inc., has disclosed 12 transactions in HCA since November 5, 2025: 0 purchases (0 open-market buys) and 5 sales, worth about $18.0M at the reported prices. The latest was filed August 28, 2026, 2 days after the trade; 3 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
5
Avg. disclosure lag
2.6d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months McAlevey Michael R made no purchases and 5 sales worth $10M, plus 7 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
McAlevey Michael R has traded 1 stock on record; the largest by dollars is HCA.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 4 | 36,340 | $4.3M |
| F | Shares withheld for tax | 3 | 15,590 | $7.6M |
| A | Grant or award | 2 | 16,439 | — |
| S | Open-market sale | 2 | 5,586 | $2.7M |
| J | Other acquisition or disposal | 1 | 7,769 | $3.3M |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 8 | 0 | 3 · $4.2M |
| 2025 | 4 | 0 | 2 · $6.1M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| HCA | Other J | August 26, 2026 | August 28, 2026 | 2d | 7,769 | $429 | $3.3M | indirect | Form 4 ↗ | |
| HCA | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 5,000 | — | — | latederivative | Form 4 ↗ | |
| HCA | Sell S | February 18, 2026 | February 18, 2026 | 0d | 1,694 | $533 | $904K | Form 4 ↗ | ||
| HCA | Sell F | February 13, 2026 | February 18, 2026 | 5d | 3,306 | $540 | $1.8M | late | Form 4 ↗ | |
| HCA | Option / conversion M | February 13, 2026 | February 18, 2026 | 5d | 5,000 | $237 | $1.2M | late | Form 4 ↗ | |
| HCA | Sell F | February 10, 2026 | February 12, 2026 | 2d | 3,006 | $502 | $1.5M | Form 4 ↗ | ||
| HCA | Other A | February 10, 2026 | February 12, 2026 | 2d | 8,372 | — | — | Form 4 ↗ | ||
| HCA | Other A | January 29, 2026 | February 2, 2026 | 4d | 8,067 | — | — | derivative | Form 4 ↗ | |
| HCA | Option / conversion M | November 3, 2025 | November 5, 2025 | 2d | 13,170 | — | — | derivative | Form 4 ↗ | |
| HCA | Sell S | November 5, 2025 | November 5, 2025 | 0d | 3,892 | $474 | $1.8M | Form 4 ↗ | ||
| HCA | Sell F | November 3, 2025 | November 5, 2025 | 2d | 9,278 | $462 | $4.3M | Form 4 ↗ | ||
| HCA | Option / conversion M | November 3, 2025 | November 5, 2025 | 2d | 13,170 | $237 | $3.1M | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 28, 2026 | Form 4 | 0001193125-26-374693 | 1 | published | EDGAR ↗ |
| February 18, 2026 | Form 4 | 0001193125-26-057701 | 4 | published | EDGAR ↗ |
| February 12, 2026 | Form 4 | 0001193125-26-049217 | 2 | published | EDGAR ↗ |
| February 2, 2026 | Form 4 | 0001193125-26-034008 | 1 | published | EDGAR ↗ |
| November 5, 2025 | Form 4 | 0001193125-25-267409 | 4 | published | EDGAR ↗ |
Other insiders at HCA Healthcare, Inc.
- HAZEN SAMUEL N CEO 19 rows
- Johnston Hugh F Director 17 rows
- Marks Mike A EVP and CFO 8 rows
- Wyatt Christopher F. SVP & Controller 7 rows
- Foster Jon M EVP and COO 6 rows
- Berres Jennifer SVP & Chief Human Res. Officer 5 rows
- CHIDSEY JOHN Director 5 rows
- Cuffe Michael S. EVP and Chief Clinical Officer 5 rows
- FRIST THOMAS F III Director 3 rows
- Frist William R Director 3 rows
Everyone on file, with contracts and lobbying under the company's name: HCA Healthcare, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 12 | November 5, 2025 | August 28, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.